Search Results

Showing results 21-31 of 34 for 'Alzheimers'


  • limitless-tn
    Limitless: Fulfilling the Potential of the Human Brain

    The human brain is “limitless” – and yet, sometimes things go wrong. In this video, Prof. Noam Sobel, Dr. Assaf Tal, Prof. Michal Schwartz, Prof. Alon Chen, Dr. Tali Kimchi, Dr. Ofer Yizhar, Prof. Daniel Zajfman, and Prof. Yadin Dudai talk about studying the brain in health and disease, always learning “what it means to be human, what it means to think, what it means to remember.”

    /news-media/video-gallery/limitless-fulfilling-the-potential-of-the-human-brain
  • the-scientist_neuroimmunity_98bf9c4f-22b8-4360-a100-673deaa74065
    Immune System Maintains Brain Health

    Prof. Michal Schwartz's groundbreaking research on neuroimmunology changed the way scientists and clinicians view the interaction between the immune system and the brain. The Scientist provides in-depth reporting on what neuroimmunology is, how it works, and why it is so important.

    /news-media/other/immune-system-maintains-brain-health
  • schwartzheader438188dac497647cb66dff00005fc039
    Prof. Michal Schwartz Will Change Your Mind

    Prof. Michal Schwartz's new book shares her breakthrough discovery that the immune system and brain communicate, and how this could lead to slowing – even reversing – brain aging and neurodegeneration.

    /news-media/other/prof-michal-schwartz-will-change-your-mind
  • rosenzweig-rina_3.jpg
    Unfolding the Mysteries of Proteins

    WeizmannViews Issue No. 46 is about the research of new young scientist Dr. Rina Rosenzweig. She is expert in using super-powerful NMR machines, applying these skills to her studies of misfolded proteins and the clumps they form. These protein “aggregates” are involved in neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s.

    /news-media/feature-stories/unfolding-the-mysteries-of-proteins
  • marshall-levin.jpg
    CEO Conference Call: Science at the Leading Edge

    On February 28, 2017, American Committee donors of all giving levels were invited to join a special conference call with CEO Marshall S. Levin. More than 100 donors from across the country participated. Mr. Levin spoke on the topic of “Science at the Leading Edge: Latest Breakthroughs from the Weizmann Institute of Science.” He opened with an overview of the Weizmann Institute and its reputation as a relatively small institution with “an outsized impact” on the world. He then discussed the Institute’s game-changing research on the aging brain, as well as the work of its Nancy and Stephen Grand Israel National Center for Personalized Medicine. Through these and other initiatives, the Institute seeks to improve the quality of life of every person on the planet.

    /news-media/feature-stories/ceo-conference-call-science-at-the-leading-edge
  • shimanovich-ulyana.jpg
    Bright Lights and Superstars: The Gruber Award for Scientific Excellence

    On March 21, the Weizmann Institute of Science’s Dr. Ulyana Shimanovich received the 11th Annual Gruber Award for Scientific Excellence. Established by philanthropist Patricia Gruber and her late husband Peter Gruber through their Gruber Foundation, the prestigious award provides valuable affirmation and support for talented young scientists just beginning their careers.

    /news-media/feature-stories/bright-lights-and-superstars-the-gruber-award-for-scientific-excellence
  • shwartz amit group.jpg
    The Brain’s Rejuvenating Cells

    Alzheimer’s disease is a neurodegenerative disease manifested by various neuronal pathological processes and a significant decline in brain function. Aggregates of beta-amyloid protein (“plaques”) accumulate within and between brain cells. Due to both structural changes and the weakening of chemical communication pathways, the junctions of neuronal networks (synapses) are lost. In addition, the cytoskeletal proteins of the axons lose their normal structure, impairing their function and causing massive neuronal death.

    /news-media/news-releases/the-brains-rejuvenating-cells
  • 2017-06-ACWIS-Enews-final.jpg
  • 2017-09-ACWIS-Enews-final.jpg
    World Alzheimer’s Month: How is Weizmann Helping?

    September is World Alzheimer’s Month – a fact that highlights the disease’s unfortunate status as a major, ongoing, global health crisis. There are many intersecting reasons that Alzheimer’s disease is on the rise; ironically, most of them are also advances, such as better healthcare, prevention, nutrition, safety, and the like, all of which lead to increased longevity. And while Alzheimer’s is a disease of the aging brain, there is also a significant genetic component to this devastating illness. As of now, despite many years and many billions of dollars, there is no truly effective treatment, much less a cure.

    /news-media/feature-stories/world-alzheimer-s-month-how-is-weizmann-helping
  • 555--A66I0261_1800.jpg
    “Lady Globes” Woman of the Year: Prof. Michal Schwartz

    Selecting the Woman of the Year is never easy; it amounts to a statement of values, meaning, and priorities. The selection is based on a single overriding value: excellence. Schwartz, who does her research at the Weizmann Institute of Science, is likely to dramatically change the course of medicine. After years of research, she discovered a mechanism for treating degenerative brain diseases that runs counter to the accepted scientific axioms. Schwartz's scientific breakthrough makes it possible to begin developing drugs for a disease regarded as the 21st century's biggest medical threat. Her research solution has far-reaching consequences.

    /news-media/in-the-news/lady-globes-woman-of-the-year-prof-michal-schwartz